Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States-Reference-Cited by-同舟云学术

Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States

Published:2024-02 Issue:2 Volume:24 Page:e21-e32.e4
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Barta Stefan K.^ORCID,Liu Nicholas^ORCID,DerSarkissian Maral,Chang Rose,Ye Mingchen^ORCID,Duh Mei Sheng,Surinach Andy,Fanale Michelle,Yu Kristina S.^ORCID

Funder

American Society of Hematology

Seagen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: cutaneous T-cell lymphomas;Zinzani;Crit Rev Oncol Hematol,2016

2. The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review;Dalal;Expert Rev Hematol,2020

3. Incidence trends of primary cutaneous T-cell lymphoma in the US from 2000 to 2018: a SEER population data analysis;Cai;JAMA Oncol,2022

4. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Willemze;Ann Oncol,2018

5. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial;Prince;Lancet,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic treatments with monoclonal antibodies in mycosis fungoides and Sézary syndrome;Dermatology Reports;2024-05-07

2. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22

3. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets;Cells;2024-03-28